TrialScope is a Persona-Calibrated AI platform. That phrase is doing real work — there's a multi-persona expert calibration mechanism behind it, a consent framework behind that, and an architectural commitment to verified professional contribution. This page explains exactly how it works and what it produces.
TrialScope is an AI-powered critical appraisal platform for clinical evidence. You give it a study, protocol, submission document, or manuscript (paste text, upload PDF, or upload a full document package). It returns a structured audit tuned for the professional role you actually do — regulatory affairs, biostatistics, medical writing, clinical operations, or any of sixteen verified personas. The audit is calibrated by the corrections of verified clinical professionals — confirmed through LinkedIn or an institutional email — whose persona-tagged feedback continuously shapes the system's reasoning for each role.
What makes this different from general AI: ChatGPT can read a clinical trial. So can Gemini. So can NotebookLM. None of them are calibrated by the specific reasoning patterns of regulatory affairs reviewers, biostatisticians, or medical writers. None of them adjust their output based on which professional persona is reading. TrialScope does both.
What makes this different from enterprise platforms: Medidata and Veeva run trials. They don't critically review trials. TrialScope is purpose-built for the review work that matters across the clinical evidence ecosystem — for the individual researcher, consultant, regulatory specialist, or methodologist evaluating trial evidence, not the pharmaceutical sponsor managing logistics.
Every clinical AI tool faces the same problem: the model can produce output that looks competent, but only a domain professional knows which output is actually useful — and what counts as "useful" varies dramatically by role. Persona Calibration closes that gap by making professional judgment the literal training signal, tagged by the persona of the contributor, so the AI learns role-specific reasoning patterns.
Here's how it works in practice. A verified clinical professional — confirmed through LinkedIn or an institutional email, and identified as, say, a regulatory affairs specialist — runs an audit. When the AI output isn't quite right — wrong severity, missed finding, overclaimed conclusion — they click the field and correct it in place. They also categorize why they made the correction: "missed regulatory implication," "false positive: pre-specified appropriately," or one of dozens of structured reason categories. The correction is stored as a structured record: what changed, from what value to what value, in what document type, under what review perspective, tagged with the contributor's verified persona.
Repeated across many audits and many contributors, those corrections become persona-specific patterns the system learns. The next time a regulatory affairs specialist reviews a CSR for submission readiness, the system pulls from regulatory-affairs-tagged corrections of similar audits as few-shot examples. A biostatistician reviewing the same document gets different few-shot examples, weighted toward methodology corrections. Over time, the same underlying corpus produces meaningfully different expert behaviors for each persona.
Not every correction counts equally. Each contribution is admitted immediately, but it enters weighted by the contributor's verification tier — a verified regulatory specialist's correction starts with more influence than a self-declared one — then earns or loses weight through peer consensus and downstream outcomes. Nothing is gated behind manual approval; weight, not a binary pass/fail, governs how much any single example shapes the AI, so a correction peers consistently confirm gains influence regardless of where it started.
The progression matters:
Every TrialScope output carries verification signals derived from its calibration source. These aren't marketing claims — they're structural statements about how the AI's reasoning was shaped for this specific audit.
Signals available on outputs:
Persona calibration depends on verified professionals contributing their domain judgment to the system. That contribution needs a formal framework — one that protects each contributor's professional inputs and the platform's freedom to operate. TrialScope's framework is called the Strategic Middle Path.
Permitted uses of calibration contributions:
Prohibited uses:
The framework lives in a Calibration Data Contribution Agreement accepted by every verified contributor before they begin work. It serves three functions simultaneously: it protects each contributor's inputs from commercial exploitation outside TrialScope's use; it preserves TrialScope's freedom to evolve and eventually be acquired; and it creates a defensible, auditable trail showing that every calibration example was contributed under a specific, documented framework — with the contributor's persona, verification confidence, and credentials snapshotted at the time of contribution.
The audit pipeline runs on Anthropic's Claude with structured prompts, persona-aware context injection, document-type-specific reasoning frames, and few-shot calibration retrieval keyed on persona, document type, and review perspective. It's a single-page web app over a managed Postgres backend, with row-level security enforcing strict per-user data isolation.
Identity and verification. Contributors verify through one of two paths — professional-network (LinkedIn) sign-in, or a confirmed email at a recognized institution — which resolves to a verification-confidence tier; optional professional credentials can raise it. Persona is drawn from a controlled taxonomy of sixteen clinical-research and adjacent roles.
Audit execution flow:
Calibration data model. Each contribution is stored with a snapshot of the contributor's persona, verification tier, and credentials as they were at the time — so the record stays accurate as profiles evolve. Corrections are normalized and categorized by reason against a structured taxonomy that distinguishes severity changes, finding edits, missed findings, and false positives — each captured with enough structure to become a reusable training signal.
Admission and quality control. Contributions are admitted continuously and earn influence over time rather than being gated behind manual approval. How much any single example shapes the AI is governed by a combination of contributor trust and corroboration from other reviewers, so no unconfirmed example dominates and genuinely useful corrections rise regardless of where they started. Admins can withdraw any example.
Taxonomy versioning. The reason taxonomy is versioned so it can evolve as clinical advisors refine it, without breaking historical calibration data — older corrections stay interpretable even as categories are revised.
Privacy controls. Documents marked Confidential at upload are handled so that corrections from those audits are retained without the underlying source content — reviewers see the corrections, never the confidential document. Audit content sent to the model is processed under Anthropic's commercial terms, which prohibit training on it.
Worth stating plainly, because trust in AI tools depends on calibrated honesty about their limits.
This is not a regulatory submission tool. Audits produced by TrialScope are decision-support deliverables for the reviewer's professional review process. They are not formatted, validated, or warranted as deliverables to regulatory agencies (FDA, EMA, PMDA, etc.). Reviewers integrate TrialScope output into their own professional review work product.
This is not a replacement for clinical judgment. Every audit output is a starting point. The system surfaces concerns and structures review; it does not make final professional judgments. Borderline calls between severity levels, nuanced therapeutic-area interpretations, and context-dependent clinical assessments all require the reviewer's expertise to resolve.
This is not a complete regulatory database. The system applies major regulatory frameworks (FDA 21 CFR, ICH E6(R2), EU CTR 536/2014, MHRA, PMDA, NMPA, Health Canada, TGA) but does not catch every guidance document or every niche regulatory requirement. Reviewers verify regulatory-specific findings against authoritative current sources.
This is currently in early access. The platform is functional and produces useful output, but is in active iteration. The persona calibration corpus is in seeding phase — most personas have limited correction history, and outputs in less-calibrated areas carry weaker verification signals. Early-access users receive outputs accompanied by appropriate framing about the stage of the system.
Free to use. Verify via LinkedIn or institutional email. Sixteen professional personas served.